The Week In... Nursing & Healthcare (17-21/12)
  • Posted on: 21/12/2018
  • Category: The Week In...

The Week In... Nursing & Healthcare (17-21/12)

In a rush? We’ve pulled together the top articles making headlines in the nursing and healthcare sectors this week, including a report revealing the high cost of undiagnosed rare diseases, a number of medicines getting close to EU approval, and GSK announcing their joint venture with Pfizer. Have a read!

Interested in Star’s innovative outsourcing and resourcing solutions?

Contact Head of Business Development, Ryan Wooller, at ryan.wooller@starmedical.co.uk, or get in touch on 07748 464 079.

On the hunt for a new role, or just curious?

Visit our candidate page, submit your CV to candidates@starmedical.co.uk, give our offices a ring, or sign up to our newsletter at the bottom of this page!

NHS to offer mature students £5k to become mental health nurses

The NHS is set to offer mature students a £5,000 bonus to become mental health or learning disability nurses as part of a long-term plan to help boost the sector.

High cost of undiagnosed rare diseases

Patients with rare diseases have cost NHS England more than £3.4 billion in the last 10 years, analysis shows.

Seven medicines leap closer to EU approval

The European Medicines Agency’s human medicines committee (CHMP) has put forward seven medicines for approval in the region.

Big pharma: GSK to split as it forms £9.8bn consumer health venture with Pfizer

GSK has revealed it has entered into an agreement with US rival Pfizer to combine their consumer health businesses into one joint venture, expected to bring in sales of approximately £9.8bn.

Immigration: White Paper sets out post-Brexit rules for migrants

Tens of thousands of low-skilled migrants could come to the UK to work for up to a year under proposed new post-Brexit immigration rules. 

While you’re here…

…and are interested in our content, why not sign up to our newsletter? It’s just below here.